Sophia Lugo
Seminars
CXOs’ Panel Discussion: Unlocking the Next Frontiers of mRNA-Based Vaccines & Therapeutics to Ensure Better Drugs Reach Patients Faster
8:30 am
- What do you think are the top 3 opportunities/near future wins for the mRNA field?
- Given your role in the C-suite, what are the biggest challenges you face on a day-to-day basis and what kind of decisions do you have to make?
- Given your role and affiliation, how do you view the market consolidation and how does it affect your day-to-day and decision making?
- What are your views on the investor climate and partnership strategies or opportunities for collaboration in the mRNA field this year?
Thursday 2nd January 2025
Radar Therapeutics: Pioneering Precision-Expressed mRNA Therapeutics
11:45 am
- Overview of Radar’s proprietary RNA sense-and-respond platform for precise expression of mRNA/gene therapeutics
- RADAR enables cell-type specific RNA expression by sensing intracellular RNA markers that define the cell type, disease state or cell state of interest to activate translation of a synthetic transcript
- RADAR enables precise, autonomous cell-selectivity that can bring specificity to broadly-targeting delivery vectors for DNA and mRNA
- Discussing the platform’s applicability to complex diseases
